(Total Views: 586)
Posted On: 02/12/2021 11:08:27 PM
Post# of 154090
Listen at 00:35
Dr. Woodcock was appointed January 20 so it's quite likely this was recorded late last year. Regardless, it's always nice to hear the head of the FDA talk about MABs and their potential.
Quote:
When the conversation was recorded, Dr. Woodcock was serving as the head of therapeutics for Operation WarpSpeed. Recently she was appointed as the acting FDA commissioner.
Dr. Woodcock was appointed January 20 so it's quite likely this was recorded late last year. Regardless, it's always nice to hear the head of the FDA talk about MABs and their potential.
(1)
(0)
